Invention Grant
- Patent Title: Methods for treating cancer using nucleic acids targeting MDM2 or MYCN
-
Application No.: US15307512Application Date: 2015-04-28
-
Publication No.: US11279934B2Publication Date: 2022-03-22
- Inventor: Michael Byrne , Karen G. Bulock , James Cardia
- Applicant: Phio Pharmaceuticals Corp.
- Applicant Address: US MA Marlborough
- Assignee: Phio Pharmaceuticals Corp.
- Current Assignee: Phio Pharmaceuticals Corp.
- Current Assignee Address: US MA Marlborough
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2015/027968 WO 20150428
- International Announcement: WO2015/168108 WO 20151105
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113
Abstract:
Aspects of the invention relate to methods for treating cancer by administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding mouse double minute 1 homolog (MDM1), mouse double minute 2 homolog (MDM2), mouse double minute 3 homolog (MDM3), mouse double minute 4 homolog (MDM4) or V-myc myelocytomatosis viral related oncogene (MYCN) for treating cancer. Further aspects of the invention relate to nucleic acid molecules and compositions comprising nucleic acid molecules.
Public/Granted literature
- US20170051288A1 METHODS FOR TREATING CANCER USING NUCLEIC ACIDS TARGETING MDM2 OR MYCN Public/Granted day:2017-02-23
Information query
IPC分类:
